Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biologics Exclusivity: GPhA Making Last Stand In Pacific

05 Jan 2015

• By Derrick Gingery

Related Content

Biologics Data Protection In Trade Agreements Becoming Key Focus For PhRMA

30 Apr 2012

CMS Budget Plan: $1 Bil. Increase For Administrative Activities Is New, But Drug Policy Proposals Are Old

13 Feb 2012

Trans-Pacific Partnership Pact Set As Test Ground For Getting Biologics Data Exclusivity At National Levels

18 Jun 2013

Additional Topics

United States Distribution Advertising, Marketing & Sales Intellectual Property Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.